Hepatitis Forums

Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on January 22, 2018, 10:19:42 am

Title: No Link Between Hep C Treatment With DAAs and Liver Cancer Risk
Post by: Hep Editors on January 22, 2018, 10:19:42 am

Direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) does not apparently raise the risk of hepatocellular carcinoma (HCC, the most common form of liver cancer) compared with interferon treatment, Healio reports. Previous reports of such a link between DAAs and liver cancer were likely biased by differences in baseline risk factors for liver cancer between those treated with interferon versus DAAs.

Regardless of treatment type, treating hep C is indeed associated with a lower risk of liver cancer.

Read more...
https://www.hepmag.com/article/link-hep-c-treatment-daas-liver-cancer-risk